DECHRA PHARMACEUTICALS DECHRA PHARMACEUTICALS PLC
The following information is provided pursuant to section 311A of the Companies Act 2006:
As at 8 September 2022 (the latest practicable time before the date on which the Notice of Annual General Meeting 2022 was given) the total number of shares in Dechra Pharmaceuticals PLC, in respect of which shareholders are entitled to exercise voting rights, was 113,766,975 ordinary shares of 1p each.
As at 8 September 2022 (the latest practicable time before the date on which the Notice of Annual General Meeting 2022 was given) the total number of votes that shareholders are entitled to exercise at the Annual General Meeting is 113,766,975.
Melanie Hall
Company Secretary
20 September 2022
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Dechra Pharmaceuticals plc published this content on 20 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 September 2022 12:49:03 UTC.
